Ochre Bio Company

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.
Technology: Biopharma, Biotechnology, Health Care, Therapeutics
Industry: Early Drug Development, Preclinical Development, Regenerative medicine
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2019-09-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 19
Total Funding: 39750000
Estimated Revenue: Less than $1M
Last Funding Date: 2022-10-10
Last Funding Type: Series A

Visit Website
contact@ochre-bio.com
https://twitter.com/OchreBio
Register and Claim Ownership